Benchmark Almanac

Long-form virology tasks

Only in system cards

Agents complete end-to-end pathogen acquisition workflows, covering workflow design and laboratory protocols. Scored against expert criteria.

Anthropic evaluation built with SecureBio, Deloitte and Signature Science. The tasks are not public. Retired in the Claude Opus 5.5 system card, which calls them largely saturated and prone to refusals, and replaced by the Protocols and BioMysteryBench evaluations.

Made by
Anthropic
Released
February 2025
Kind
Hazardous knowledge
Level
Expert
Scored
Graded by people
Answers
Agent task
Tasks
Kept private
Strongest model tested
Claude 3.7 Sonnet #118 on the capability index
Last in a system card
July 2026
Last model added
July 2026
1
Model scored in lab cards
14
System cards report it, from 1 lab

Claude 3.7 Sonnet leads with 69.7%

Best score per model as labs report them in their own cards. Labs pick their own settings, so these compare less cleanly than independent runs.

  1. 1 Claude 3.7 Sonnet 69.7%

Source: Labs’ model cards

#ModelScoreSettingDateSource
1 Claude 3.7 Sonnet 69.7% Feb 2025 Lab model card

Scores over time

All the scores we have, one dot each, so a model tested at several settings appears more than once.

Reported by the lab in its model card
0% 20% 40% 60% 80% 100% 2025 Near the ceiling (85%) Claude 3.7 Sonnet 0% 20% 40% 60% 80% 100% 2025 Near the ceiling (85%) Claude 3.7 Sonnet

Source: Labs’ model cards

Labs report it only in system cards

We read the headline results of 522 launch posts from 52 labs, and none of them list this benchmark. Some system cards do, below.

14 system cards report it, from 1 lab

Besides launch posts, we read the system cards, model cards and technical reports labs publish with a release. They report far more, including safety and frontier-risk tests.

DateDocumentScoreAs the document writes itSection
Jul 24, 2026 Claude Opus 5 system card Long-form virology tasks, two tasks with no overall: Task 1 end-to-end 0.802 and Task 2 end-to-end 0.872 (0.87 on chart), highest-scoring snapshot (2.2.4, Figure 2.2.4.A) Bio and chem risk
Jun 30, 2026 Claude Sonnet 5 system card Long-form virology tasks, end-to-end score Task 1 0.79 and Task 2 0.90, no overall, highest score across snapshots (2.2.4, Figure 2.2.4.A) Bio and chem risk
May 28, 2026 Claude Opus 4.8 system card Long-form virology tasks, two tasks with no overall: task 1 end-to-end 0.77 (sequence design 0.88, protocol design 0.87), task 2 end-to-end 0.90 (sequence design 1.00, protocol design 0.90, corrected from 0.89 in the June 17, 2026 changelog) (Table 2.2.3.B, 2.2.4) Bio and chem risk
Apr 16, 2026 Claude Opus 4.7 system card Long-form virology tasks, end-to-end score, task 1 0.82 and task 2 0.94, no overall, highest score across snapshots (2.2.5.2, Figure 2.2.5.2.A) Bio and chem risk
Apr 7, 2026 Claude Mythos Preview system card Long-form virology tasks, end-to-end score, task 1 0.81 and task 2 0.94, no overall (2.2.5.4, Figure 2.2.5.4.A) Bio and chem risk
Feb 17, 2026 Claude Sonnet 4.6 system card Long-form virology tasks, max of 5 score, task 1 0.84 and task 2 0.89, no overall (6.2.2.1) Bio and chem risk
Feb 5, 2026 Claude Opus 4.6 system card Long-form virology tasks, max of 5 score, task 1 (influenza) 0.79 and task 2 (SARS-CoV) 0.9, no overall (8.2.4.1) Bio and chem risk
Nov 24, 2025 Claude Opus 4.5 system card Long-form virology tasks, two tasks with no overall: task 1 max of 5 score 0.845, task 2 pass@5 score 0.912 (7.2.4.1) Bio and chem risk
Oct 15, 2025 Claude Haiku 4.5 system card Long-Form Virology Task 1 0.76 (Sequence 0.87, Protocol 0.88) and Task 2 0.17 (Sequence 0.19, Protocol 0.87), no overall (6.2.3.1) Bio and chem risk
Sep 29, 2025 Claude Sonnet 4.5 system card Long-form virology tasks, two tasks with no overall: Task 1 max of 5 end-to-end score 0.89 (sequence design 0.98, protocol design 0.90), Task 2 pass@5 end-to-end score 0.88 (sequence 0.97, protocol 0.91) (9.2.4.1, Figures 9.2.4.1.A and 9.2.4.1.B) Bio and chem risk
Aug 5, 2025 Claude Opus 4.1 system card addendum Long-form virology tasks, two tasks with no overall: Task 1 score 0.86 (sequence design 0.98, protocol design 0.87), Task 2 score 0.67 (sequence design 0.85, protocol design 0.79) (6.3.1.2) Bio and chem risk
May 22, 2025 Claude Sonnet 4 system card Long-form virology tasks, two tasks with no overall: Task 1 end-to-end max of 5 score 0.55, Task 2 end-to-end pass@5 score 0.635 (7.2.4.3, Figures 7.2.4.3.A and B) Bio and chem risk
May 22, 2025 Claude Opus 4 system card Long-form virology tasks, two tasks with no overall: Task 1 end-to-end max of 5 score 0.83, Task 2 end-to-end pass@5 score 0.720 (7.2.4.3, Figures 7.2.4.3.A and B) Bio and chem risk
Feb 24, 2025 Claude 3.7 Sonnet system card 69.7 Long-form virology tasks, score 69.7% under the most conservative scoring (7.1.4) Bio and chem risk

More in Biology and chemistry

All 108 in Biology and chemistry
  • GeneBench Pro In use Agents analyze messy simulated genomics and biology datasets to estimate a decision-relevant quantity across 129 problems. Scored automatically against known answers. GPT-5.6 Sol 31.5%
  • SUPERChem In use Models solve 500 expert-written chemistry reasoning problems, offered in multimodal and text-only forms. Expert solution paths also allow a reasoning path score. Tencent Hy4 preview 66.4%
  • LifeSciBench In use Models complete 750 expert-written life science research tasks, often with attached figures, tables, or sequence files. Graded against expert rubrics as score and pass rate. GPT-Rosalind-6 61.3%
  • MedChemBench (OpenAI) In use Models answer chemistry questions from an OpenAI internal set, grouped with OpenAI's life science research evaluations. OpenAI has not published the task format. GPT-Rosalind-6 49.6%
  • ProtocolQA Open-Ended In use Models correct errors in published lab protocols using open-ended questions adapted from LAB-Bench ProtocolQA. Scored as pass@1. GPT-6 Cyber 47.2%
  • MolecularIQ In use Models answer questions about molecular graphs, such as counting, indexing and constrained generation, and a symbolic checker verifies each answer. gpt-oss-120b 47.5%